Showing 1 - 3 results of 3 for search 'J. A. Nadal', query time: 0.03s Refine Results
  1. 1
    P1060: REAL-WORLD CLINICAL OUTCOMES AFTER 3 AND 6 MONTHS OF TREATMENT WITH FEDRATINIB FOLLOWING RUXOLITINIB FAILURE

    P1060: REAL-WORLD CLINICAL OUTCOMES AFTER 3 AND 6 MONTHS OF TREATMENT WITH FEDRATINIB FOLLOWING RUXOLITINIB FAILURE by J. Mascarenhas, A. T. Gerds, J. K. Kish, P. Abraham, A. Balanean, J. A. Nadal, D. Liassou, B. A. Feinberg, A. McBride, C. Harrison

    Published 2022-06-01
    Get full text
    Article
  2. 2
    P1057: REAL-WORLD UTILIZATION OF FEDRATINIB FOR MYELOFIBROSIS FOLLOWING RUXOLITINIB FAILURE

    P1057: REAL-WORLD UTILIZATION OF FEDRATINIB FOR MYELOFIBROSIS FOLLOWING RUXOLITINIB FAILURE by C. Harrison, J. Mascarenhas, P. Abraham, J. A. Nadal, A. Balanean, A. McBride, J. K. Kish, D. Liassou, B. A. Feinberg, A. T. Gerds

    Published 2022-06-01
    Get full text
    Article
  3. 3
    P778: LONG-TERM UTILIZATION AND BENEFIT OF LUSPATERCEPT IN PATIENTS (PTS) WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) FROM THE MEDALIST TRIAL

    P778: LONG-TERM UTILIZATION AND BENEFIT OF LUSPATERCEPT IN PATIENTS (PTS) WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) FROM THE MEDALIST TRIAL by P. Fenaux, V. Santini, R. S. Komrokji, A. Zeidan, G. Garcia-Manero, R. Buckstein, D. Miteva, K. Keeperman, N. Holot, J. Zhang, J. A. Nadal, B. Rosettani, A. Yucel, U. Platzbecker

    Published 2022-06-01
    Get full text
    Article

Search Tools: